You are viewing an incomplete version of our website. Please click to reload the website as full version.

CTLA4 antibody (Cytotoxic T-Lymphocyte-Associated Protein 4) (PE)

Details for Product anti-CTLA4 Antibody No. ABIN135316, Supplier: Log in to see
Antigen
  • CTLA-4
  • CTLA4
  • CD152
  • Cd152
  • Ctla-4
  • Ly-56
  • CD
  • CELIAC3
  • GRD4
  • GSE
  • IDDM12
  • sCTLA4
  • cytotoxic T-lymphocyte-associated protein 4 precursor
  • cytotoxic T-lymphocyte-associated protein 4
  • CTLA-4
  • CTLA4
  • LOC100222727
  • Ctla4
Reactivity
Mouse (Murine)
219
209
82
19
2
2
Host
Hamster
211
89
75
29
27
5
3
Clonality (Clone)
Monoclonal ()
Conjugate
This CTLA4 antibody is conjugated to PE
57
37
35
14
7
7
7
7
6
6
6
6
5
5
5
5
5
3
3
3
3
2
2
1
1
1
1
Application
Flow Cytometry (FACS)
287
183
168
67
64
59
50
20
17
12
9
6
5
4
4
4
4
4
3
2
2
2
2
2
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Clone 1B8
Isotype IgG
Characteristics The antibody detects: Mouse CD152/CTLA-4
Alternative Name CD152/CTLA-4 (CTLA4 Antibody Abstract)
Background The lymphocyte surface antigen CD152, also known as CTLA-4, is related to the co-stimulatory molecule CD28, and both molecules share common B7 family counter-receptors. However CD152 is thought to be a negative regulator of T cell activation and may play a role in apoptotic control of T cells. CD152 exists as a 69 kDa homodimer, and is relatively conserved among humans, mice and chickens.
Application Notes Working Dilution:
FACS: 03 µg/10^6 cells
Representative data are included in this product insert.

Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Comment

In vitro functional studies

Sample Volume 1 mL
Restrictions For Research Use only
Buffer Product is supplied as 0.1 mg in 1.0 mL of PBS / NaN3 and a stabilizing agent.
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handling Advice Do not freeze!
Protect conjugated products from light.

Each reagent is stable for the period shown on the bottle label if stored as directed.
Storage 4 °C
Background publications Leach, Krummel, Allison: "Enhancement of antitumor immunity by CTLA-4 blockade." in: Science (New York, N.Y.), Vol. 271, Issue 5256, pp. 1734-6, 1996 (PubMed).

Perkins, Wang, Donovan, He, Mark, Guan, Wang, Walunas, Bluestone, Listman, Finn: "Regulation of CTLA-4 expression during T cell activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 156, Issue 11, pp. 4154-9, 1996 (PubMed).

Walunas, Lenschow, Bakker, Linsley, Freeman, Green, Thompson, Bluestone: "CTLA-4 can function as a negative regulator of T cell activation." in: Immunity, Vol. 1, Issue 5, pp. 405-13, 1995 (PubMed).

Freeman, Lombard, Gimmi, Brod, Lee, Laning, Hafler, Dorf, Gray, Reiser: "CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 149, Issue 12, pp. 3795-801, 1993 (PubMed).